On Monday, Shares of OncoGenex Pharmaceuticals Inc (NASDAQ:OGXI), gained 15.02% to $3.60.
OncoGenex Pharmaceuticals, declared that its Phase 3 ENSPIRIT trial evaluating custirsen in the treatment of advanced or metastatic non-small cell lung cancer (NSCLC) is ongoing as planned per the recommendation of an Independent Data Monitoring Committee (IDMC). This decision was based upon completion of the second and final planned interim futility analysis.
“Passing this important milestone strengthens our belief in custirsen and its potential to provide clinical benefit in this patient population with advanced disease and limited treatment options,” said Scott Cormack, President and CEO of OncoGenex. “While the ENSPIRIT results remain blinded, this news is particularly exciting following the protocol amendment, which set a high bar for ongoing the trial.”
OncoGenex Pharmaceuticals, Inc., a biopharmaceutical company, develops and commercializes therapies that address treatment resistance in cancer patients. The company’s product candidates comprise Custirsen that is in Phase III clinical development for the treatment in men with metastatic castrate-resistant prostate cancer, in addition to in patients with non-small cell lung cancer; and Apatorsen, which is in two Phase I and seven randomized Phase II trials for the treatment of bladder, lung, pancreatic, and prostate cancers.
Shares of FMC Technologies, Inc. (NYSE:FTI), declined -0.64% to $32.63, during its last trading session.
FMC Technologies, stated second quarter 2015 revenue of $1.7 billion, down 15 percent from the preceding-year quarter primarily due to the continued decline in the North American land market and its severe impact on our Surface Technologies segment revenue. Diluted earnings per share were $0.46 which comprised of pre-tax business restructuring charges of $9.5 million, or $0.03 per diluted share, and a U.S. tax charge of $8.0 million, or $0.03 per diluted share, related to a tax settlement.
Total inbound orders were $1.4 billion, counting $1.0 billion in Subsea Technologies orders. Backlog for the Company was $5.3 billion, counting Subsea Technologies backlog of $4.7 billion.
FMC Technologies, Inc. provides technology solutions for the energy industry worldwide. The company operates through Subsea Technologies, Surface Technologies, and Energy Infrastructure segments. The Subsea Technologies segment offers subsea systems for the offshore production of crude oil and natural gas; and well access and flow administration services, counting installation and workover tools, service technicians for installation assistance, and field support services.
At the end of Monday’s trade, Shares of Atmel Corporation (NASDAQ:ATML), lost -1.15% to $8.56.
Atmel Corporation, will hold a conference call Tuesday, July 28, 2015 at 2 p.m. PT to talk about its second quarter 2015 financial results. Atmel President and CEO, Steven Laub, and Senior Vice President and CFO, Steve Skaggs, will be participating on this call. The earnings release will be issued at the close of market that same day.
Atmel Corporation designs, develops, manufactures, and sells semiconductor integrated circuit products primarily in the United States, Asia, Europe, South Africa, and Central and South America. It operates in four segments: Microcontroller, Nonvolatile Memory, Automotive, and Multi-Market and Other.
Finally, Infosys Ltd ADR (NYSE:INFY), ended its last trade with -2.84% loss, and closed at $16.74.
Infosys, has been inducted into the ‘Winner’s Circle’ in the inaugural Engineering Services Blueprint report by leading analyst firm HfS Research. Companies that demonstrate excellence in execution and innovation are placed in the ‘Winner’s Circle’ by HfS.
The report commended Infosys for exhibiting a high level of planned vision, innovation-led thinking, and strong client relationships. Infosys has been listed among the leaders in key verticals, counting automotive, aerospace and defense, telecom and hi-tech in addition to in medical devices and industrial equipment.
Infosys Limited, together with its auxiliaries, provides business consulting, technology, engineering, and outsourcing services in North America, Europe, India, and internationally.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should might occur.
